276 related articles for article (PubMed ID: 15701782)
1. Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.
Kalus JS; Moser LR
Ann Pharmacother; 2005 Mar; 39(3):481-91. PubMed ID: 15701782
[TBL] [Abstract][Full Text] [Related]
2. Role of low-molecular-weight heparin in invasive management of non-ST-elevation acute coronary syndromes.
Moser LR; Kalus JS
Ann Pharmacother; 2004 Dec; 38(12):2094-104. PubMed ID: 15536140
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials.
De Luca G; Marino P
Am Heart J; 2007 Dec; 154(6):1085.e1-6. PubMed ID: 18035079
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparins in conjunction with thrombolysis for ST-elevation acute myocardial infarction. A critical review of the literature.
Rubboli A; Ottani F; Capecchi A; Brancaleoni R; Galvani M; Swahn E
Cardiology; 2007; 107(2):132-9. PubMed ID: 16864962
[TBL] [Abstract][Full Text] [Related]
5. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
[TBL] [Abstract][Full Text] [Related]
6. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
Eikelboom JW; Quinlan DJ; Mehta SR; Turpie AG; Menown IB; Yusuf S
Circulation; 2005 Dec; 112(25):3855-67. PubMed ID: 16344381
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
[TBL] [Abstract][Full Text] [Related]
8. ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis.
Gabriel RS; White HD
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):851-7. PubMed ID: 17867915
[TBL] [Abstract][Full Text] [Related]
9. Comparison of low molecular weight heparin with unfractionated heparin during percutaneous coronary interventions: a meta-analysis.
Kodumuri V; Adigopula S; Singh P; Swaminathan P; Arora R; Khosla S
Am J Ther; 2011 May; 18(3):180-9. PubMed ID: 20027109
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
Gibson CM; Murphy SA; Montalescot G; Morrow DA; Ardissino D; Cohen M; Gulba DC; Kracoff OH; Lewis BS; Roguin N; Antman EM; Braunwald E;
J Am Coll Cardiol; 2007 Jun; 49(23):2238-46. PubMed ID: 17560287
[TBL] [Abstract][Full Text] [Related]
11. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.
Dumaine R; Borentain M; Bertel O; Bode C; Gallo R; White HD; Collet JP; Steinhubl SR; Montalescot G
Arch Intern Med; 2007 Dec; 167(22):2423-30. PubMed ID: 18071163
[TBL] [Abstract][Full Text] [Related]
12. A critical review of the efficacy and safety in the use of low-molecular-weight heparin in acute ST-elevation myocardial infarction: a Bayesan approach.
Buccelletti E; Spadaccio C; Chello M; Marsiliani D; Carroccia A; Iacomini P; Calabrò G; Gentiloni Silveri N; Franceschi F
Eur Rev Med Pharmacol Sci; 2011 Jun; 15(6):701-10. PubMed ID: 21796875
[TBL] [Abstract][Full Text] [Related]
13. Use of anticoagulants in ST-segment elevation myocardial infarction patients; a focus on low-molecular-weight heparin.
Gurm HS; Eagle KA
Cardiovasc Drugs Ther; 2008 Feb; 22(1):59-69. PubMed ID: 18165932
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy in unstable angina/non-ST elevation myocardial infarction: the evolving role of low-molecular-weight heparin.
Antman EM; Kereiakes DJ
J Invasive Cardiol; 2000 Dec; 12 Suppl E():E1-4;discussion E25-8. PubMed ID: 11156721
[TBL] [Abstract][Full Text] [Related]
16. The use of antithrombotics for acute coronary syndromes in the emergency department: considerations and impact.
Mukherjee D; Eagle KA
Prog Cardiovasc Dis; 2007; 50(3):167-80. PubMed ID: 17976502
[TBL] [Abstract][Full Text] [Related]
17. Use of anticoagulants in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: a potential role for enoxaparin.
Christy GW
J Invasive Cardiol; 2008 Nov; 20(11):615-21. PubMed ID: 18987403
[TBL] [Abstract][Full Text] [Related]
18. Acute and prolonged treatment with low-molecular-weight heparin therapy in patients with unstable coronary artery disease.
Husted S; Kher A
Ann Med; 2000 Dec; 32 Suppl 1():53-9. PubMed ID: 11209983
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis.
Murphy SA; Gibson CM; Morrow DA; Van de Werf F; Menown IB; Goodman SG; Mahaffey KW; Cohen M; McCabe CH; Antman EM; Braunwald E
Eur Heart J; 2007 Sep; 28(17):2077-86. PubMed ID: 17600038
[TBL] [Abstract][Full Text] [Related]
20. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.
Morrow DA; Antman EM; Murphy SA; Qin J; Ruda M; Guneri S; Jacob AJ; Budaj A; Braunwald E;
Am Heart J; 2007 Dec; 154(6):1078-84, 1084.e1. PubMed ID: 18035078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
